
Please try another search
Investing.com - Baxter (NYSE:BAX) reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that was inline with expectations.
Baxter announced earnings per share of $1.02 on revenue of $3.23B. Analysts polled by Investing.com anticipated EPS of $0.9384 on revenue of $3.23B.
Baxter shares are down 6% from the beginning of the year and are trading at $81.94 , down-from-52-week-high.They are under-performing the Nasdaq which is up 18.21% from the start of the year.
Baxter's report follows an earnings beat by J&J on Tuesday, October 19, 2021, who reported EPS of $2.6 on revenue of $23.34B, compared to forecasts EPS of $2.35 on revenue of $23.64B.
Thermo Fisher Scientific had beat expectations on Wednesday with third quarter EPS of $5.76 on revenue of $9.33B, compared to forecast for EPS of $4.68 on revenue of $8.33B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.